You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 16, 2024

Claims for Patent: 11,020,382

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 11,020,382

Title:	Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzald- ehyde
Abstract:	Provided herein are methods for treating sickle cell disease, comprising administering to a subject 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)-methoxy)benzal- dehyde (Compound 1), or a polymorph thereof, in certain dosing regimens.
Inventor(s):	Ramos; Eleanor L. (South San Francisco, CA), Lehrer-Graiwer; Joshua Eli (South San Francisco, CA), Hutchaleelaha; Athiwat (South San Francisco, CA)
Assignee:	Global Blood Therapeutics, Inc. (South San Francisco, CA)
Application Number:	15/368,142
Patent Claims:	1. A method for treating sickle cell disease in a human patient in need thereof comprising administering to the patient Compound 1: ##STR00003## wherein Compound 1 is administered orally in a dose of about 1500 mg once daily; and Compound 1 is in a crystalline ansolvate form characterized by X-ray powder diffraction peaks (Cu K.alpha. radiation) at 13.37.degree., 14.37.degree., 19.95.degree. and 23.92.degree. 2.theta., each peak is .+-.0.2.degree. 2.theta.. 2. A method for increasing hemoglobin to treat sickle cell disease in a human patient in need thereof comprising administering to the patient Compound 1: ##STR00004## wherein Compound 1 is administered orally in a dose of about 1500 mg once daily; and Compound 1 is in a crystalline ansolvate form characterized by X-ray powder diffraction peaks (Cu K.alpha. radiation) at 13.37.degree., 14.37.degree., 19.95.degree. and 23.92.degree. 2.theta., each peak is .+-.0.2.degree. 2.theta..

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.